Next, the FCM assay was performed to determine cell apoptosis, and we expectedly found that silencing of CXCR4 increased Annexin V-FITC/PI-positive apoptotic cell ratio in the ccRCC cells (Figure 2(h-j)). This evidence concerns the gene CXCR4 and nonpapillary renal cell carcinoma.